Back to Search
Start Over
Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis
- Source :
- Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-9 (2018), Arthritis Research & Therapy
- Publication Year :
- 2018
- Publisher :
- Springer Science and Business Media LLC, 2018.
-
Abstract
- Background The chemokine receptors CXCR3 and CXCR4 are involved in the pathogenesis of fibrosis, a key feature of systemic sclerosis (SSc). It is hypothesized that immunoglobulin (Ig)G antibodies (abs) against these two receptors are present in patients with SSc and are associated with clinical findings. Methods Anti-CXCR3 and anti-CXCR4 ab levels were measured in 449 sera from 327 SSc patients and in 234 sera from healthy donors (HD) by enzyme-linked immunosorbent assay (ELISA). In SSc, ab levels were compared with clinical data in a cross-sectional and longitudinal setting. Protein expression of CXCR3 and CXCR4 on peripheral blood mononuclear cells (PBMCs) was analyzed in 17 SSc patients and 8 HD by flow cytometry. Results Anti-CXCR3 and anti-CXCR4 ab levels were different among SSc subgroups compared with HD and were highest in diffuse SSc patients. The ab levels strongly correlated with each other (r = 0.85). Patients with SSc-related interstitial lung disease (SSc-ILD) exhibited higher ab levels which negatively correlated with lung function parameters (e.g., r = −0.5 and r = −0.43 for predicted vital capacity, respectively). However, patients with deterioration of lung function showed lower anti-CXCR3/4 ab levels compared with those with stable disease. Frequencies and median fluorescence intensities (MFI) of CXCR3+ and CXCR4+ PBMCs were lower in SSc patients compared with HD and correlated with the severity of skin and lung fibrosis. They correlated with the severity of skin and lung fibrosis. Conclusions Anti-CXCR3/4 abs and their corresponding receptors are linked with the severity of SSc-ILD. Antibody levels discriminate patients with stable or decreasing lung function and could be used for risk stratification. Electronic supplementary material The online version of this article (10.1186/s13075-018-1545-8) contains supplementary material, which is available to authorized users.
- Subjects :
- Adult
Lung Diseases
Male
0301 basic medicine
Receptors, CXCR4
Receptors, CXCR3
lcsh:Diseases of the musculoskeletal system
Interstitial lung disease
CXCR3
Pathogenesis
03 medical and health sciences
Chemokine receptor
GPCR
0302 clinical medicine
Predictive Value of Tests
Fibrosis
medicine
Humans
skin and connective tissue diseases
Lung
Autoantibodies
030203 arthritis & rheumatology
Scleroderma, Systemic
integumentary system
biology
business.industry
Autoantibody
Middle Aged
Anti-CXCR4
medicine.disease
Respiratory Function Tests
Anti-CXCR3
Cross-Sectional Studies
030104 developmental biology
medicine.anatomical_structure
Immunology
Disease Progression
biology.protein
Systemic sclerosis
Female
lcsh:RC925-935
Antibody
business
Biomarkers
Research Article
Subjects
Details
- ISSN :
- 14786362
- Volume :
- 20
- Database :
- OpenAIRE
- Journal :
- Arthritis Research & Therapy
- Accession number :
- edsair.doi.dedup.....b239df7dbfa0308eea35a756cc906596